Form 8-K - Current report:
SEC Accession No. 0001641172-25-006356
Filing Date
2025-04-28
Accepted
2025-04-28 09:00:30
Documents
18
Period of Report
2025-04-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47074
2 ex1-1.htm EX-1.1 300025
3 ex5-1.htm EX-5.1 12817
4 ex5-1_001.jpg GRAPHIC 9069
5 ex5-1_002.jpg GRAPHIC 23240
  Complete submission text file 0001641172-25-006356.txt   701326

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bfrg-20250425.xsd EX-101.SCH 3718
7 XBRL DEFINITION FILE bfrg-20250425_def.xml EX-101.DEF 29945
8 XBRL LABEL FILE bfrg-20250425_lab.xml EX-101.LAB 36511
9 XBRL PRESENTATION FILE bfrg-20250425_pre.xml EX-101.PRE 26968
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5645
Mailing Address 325 ELLINGTON BLVD. UNIT 317 GAITHERSBURG MD 20878
Business Address 325 ELLINGTON BLVD. UNIT 317 GAITHERSBURG MD 20878 3013672055
BullFrog AI Holdings, Inc. (Filer) CIK: 0001829247 (see all company filings)

EIN.: 844786155 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41600 | Film No.: 25876305
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)